BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 341247)

  • 1. Trial of BCG immunotherapy in the treatment of resectable sequamous cell carcinoma of the bronchus (stages I and II).
    Pouillart P; Mathé G; Palangie T; Schwarzenberg L; Huguenin P; Morin P; Gautier H; Baron A
    Recent Results Cancer Res; 1977; (62):151-5. PubMed ID: 341247
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).
    Jansen HM; The TH; de Gast GC; Esselink MT; van der Wal AM; Orie NG
    Thorax; 1978 Aug; 33(4):429-38. PubMed ID: 358479
    [No Abstract]   [Full Text] [Related]  

  • 3. Attempt at immunotherapy with living BCG in patients with bronchus carcinoma.
    Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G
    Recent Results Cancer Res; 1978; 68():260-7. PubMed ID: 752864
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.
    Jansen HM; The TH; Orie NG
    Thorax; 1980 Oct; 35(10):781-7. PubMed ID: 7466726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non resectable squamous cell carcinoma of the bronchus. Study of the immunological status as prognosis factor and attempt at immunorestoration with B.C.G. (author's transl)].
    Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G; Lededente A; Botto G
    Nouv Presse Med; 1978 Jan; 7(4):265-9. PubMed ID: 345229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stratified randomized study of intradermal BCG in patients with carcinoma of the bronchus: prolongation of quality but not length of life in inoperable patients.
    Anthony HM; Madsen KE; Mason MK; Templeman GH
    Cancer; 1978 Oct; 42(4):1784-92. PubMed ID: 213186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
    Warren SE; Crispen RG; Nika B
    Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy as an adjuvant to surgery in carcinoma of bronchus. Results in three randomised trials.
    Roeslin N; Dumont P; Morand G; Wihlm JM; Witz JP
    Eur J Cardiothorac Surg; 1989; 3(5):430-5. PubMed ID: 2483977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunorestoration in epidermoid cancer of the bronchi. Therapeutic results (proceedings)].
    Pouillart P; Palangie T; Jouve M; Huguenin P; Gautier H; Morin P; Baron A
    J Radiol Electrol Med Nucl; 1978 Nov; 59(11):654-7. PubMed ID: 748546
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prognostic value of PPD test in patients with bronchial carcinoma treated by BCG vaccine (author's transl)].
    Jakasa D
    Plucne Bolesti Tuberk; 1977; 29(3-4):265-8. PubMed ID: 609635
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of bronchial cancer with a water-saline extract of BCG].
    Khadzhiev S; Kavaklieva-Dimitrova Ia
    Vopr Onkol; 1971; 17(8):51-7. PubMed ID: 4943964
    [No Abstract]   [Full Text] [Related]  

  • 12. A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung.
    Lachmann PJ; Grant RM; Freedman LS; Sikora K; Bleehen NM
    Br J Cancer; 1985 Mar; 51(3):415-7. PubMed ID: 3882114
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bronchus carcinoma and clinical judgment].
    Sluiter HJ
    Ned Tijdschr Geneeskd; 1973 Mar; 117(10):373-5. PubMed ID: 4688741
    [No Abstract]   [Full Text] [Related]  

  • 14. E and EAC rosetting lymphocytes in patients with carcinoma of bronchus. II. A sequential study of thirty patients: effect of BCG.
    Anthony HM; Kirk JA; Madsen KE; Mason MK; Templeman GH
    Clin Exp Immunol; 1975 Apr; 20(1):41-54. PubMed ID: 54235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG plus levamisole following irradiation of advanced squamous bronchial carcinoma.
    Pines A
    Int J Radiat Oncol Biol Phys; 1980 Aug; 6(8):1041-2. PubMed ID: 7419462
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional immunotherapy in resectable squamous cell lung carcinoma. Analysis of a randomized study.
    Roeslin N; Lang JM; Morand G; Wihlm JM; Witz JP
    Cancer Immunol Immunother; 1982; 13(3):174-5. PubMed ID: 6925982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study on the effect of BCG vaccination in patients with bronchial carcinoma.
    Nilsson BS; Afeldt PE
    Scand J Respir Dis; 1975 Aug; 56(2):84-6. PubMed ID: 1172630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary trends of the EORTC study comparing postoperative chemotherapy, immunotherapy, chemoimmunotherapy or abstention in squamous cell bronchial carcinoma.
    Israel L; Depierre A; Sylvester R
    Recent Results Cancer Res; 1978; 68():244-5. PubMed ID: 752863
    [No Abstract]   [Full Text] [Related]  

  • 19. [5 years of nonspecific active immunotherapy with a transformed mycobacterium in operated primary bronchial cancers. Study of postoperative survival of from 1 to 3 years].
    Djurovic V; Decroix G
    Ann Med Interne (Paris); 1978 Apr; 129(4):237-42. PubMed ID: 666198
    [No Abstract]   [Full Text] [Related]  

  • 20. Complications of intrapleural BCG in the treatment of operable non-small-cell bronchial carcinoma.
    Law MR; Lam WK; Studdy PR; Pugsley WB; Hodson ME
    Br J Dis Chest; 1982 Apr; 76(2):151-6. PubMed ID: 7093133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.